These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5295563)

  • 1. The degree of protection given by living vaccines against experimental infection with Brucella melitensis in goats.
    Morgan WJ; Littlejohn AI; Mackinnon DJ; Lawson JR
    Bull World Health Organ; 1966; 34(1):33-40. PubMed ID: 5295563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunization of ewes against experimental Brucella melitensis infection: comparison of eleven vaccines].
    Gaumont R; Trap D; Gayot G; Pierre F; Dhennin L
    Dev Biol Stand; 1976; 31():377-86. PubMed ID: 944151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
    Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
    Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis.
    Durán-Ferrer M; Léon L; Nielsen K; Caporale V; Mendoza J; Osuna A; Perales A; Smith P; De-Frutos C; Gómez-Martín B; Lucas A; Chico R; Delgado OD; Escabias JC; Arrogante L; Díaz-Parra R; Garrido F
    Vet Microbiol; 2004 Jun; 100(3-4):219-31. PubMed ID: 15145500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between subcutaneous and conjunctival route of vaccination with Rev. 1 strain against Brucella melitensis infection in ewes.
    Fensterbank R; Pardon P; Marly J
    Ann Rech Vet; 1982; 13(4):295-301. PubMed ID: 7185320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: serologic tests.
    Jones LM; García-Carrillo C; Alton GG
    Am J Vet Res; 1973 Feb; 34(2):199-202. PubMed ID: 4631096
    [No Abstract]   [Full Text] [Related]  

  • 10. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: pattern of immunoglobulin production after vaccination and challenge.
    Varela-Diaz VM; Jones LM; Perez-Esandi MV
    Am J Vet Res; 1973 Feb; 34(2):203-7. PubMed ID: 4631097
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity and protective activity in pregnant goats of a Brucella melitensis Deltaomp25 deletion mutant.
    Edmonds MD; Cloeckaert A; Hagius SD; Samartino LE; Fulton WT; Walker JV; Enright FM; Booth NJ; Elzer PH
    Res Vet Sci; 2002 Jun; 72(3):235-9. PubMed ID: 12076120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis.
    Kahl-McDonagh MM; Elzer PH; Hagius SD; Walker JV; Perry QL; Seabury CM; den Hartigh AB; Tsolis RM; Adams LG; Davis DS; Ficht TA
    Vaccine; 2006 Jun; 24(24):5169-77. PubMed ID: 16697090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological titres following vaccination of sheep and goats with Brucella melitensis rev I vaccine.
    Worthington RW; Mülders MS; McFarlane IS; Becker D
    Onderstepoort J Vet Res; 1973 Mar; 40(1):1-5. PubMed ID: 4197921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Persistence of serologic and allergic reactions in ewes after vaccination with the H.38 or Rev.1 vaccines in a brucellosis (Brucella melitensis) enzootic area].
    Pardon P; Sanchis R; Molenat G; Bouchard N; Schmitt D; Marly J; Durand M
    Ann Rech Vet; 1989; 20(1):65-72. PubMed ID: 2930135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: immunity.
    Alton GG; Jones LM; García-Carrillo C; Trenchi A
    Am J Vet Res; 1972 Sep; 33(9):1747-51. PubMed ID: 4626469
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence strain Rev. 1.
    Higgins JL; Bowen RA; Gonzalez-Juarrero M
    Vet Immunol Immunopathol; 2018 Aug; 202():74-84. PubMed ID: 30078602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against Brucella infection. 8. The response of Cynomolgus philippinensis, guinea-pigs and pregnant goats to injection by the Rev I strain of Brucella melitensis.
    ELBERG SS; FAUNCE WK
    Bull World Health Organ; 1962; 26(3):421-36. PubMed ID: 13889789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.